Low-Cost Drugs in Poor Nations Get a Lift in Indian Court
By GARDINER HARRIS and KATIE THOMAS
Published: April 1, 2013
The debate over global drug pricing is one of the most contentious issues between developed countries and the developing world. While poorer nations maintain they have a moral obligation to make cheaper, generic drugs available to their populations — by limiting patents in some cases — the brand name pharmaceutical companies contend the profits they reap are essential to their ability to develop and manufacture innovative medicines. [Read more] ...